1033302-98-5Relevant articles and documents
Discovery of pyrazolones as novel carboxylesterase 2 inhibitors that potently inhibit the adipogenesis in cells
Qian, Xing-Kai,Zhang, Jing,Song, Pei-Fang,Zhao, Yi-Su,Ma, Hong-Ying,Jin, Qiang,Wang, Dan-Dan,Guan, Xiao-Qing,Li, Shi-Yang,Bao, XiaoZe,Zou, Li-Wei
, (2021/05/10)
Carboxylesterase 2 (CES2) is one of the most important Phase I drug metabolizing enzymes in the carboxylesterase family. It plays crucial roles in the bioavailability of oral ester prodrugs and the therapeutic effect of some anticancer drugs such as irino
The first successful intermolecular Heck reaction of Baylis-Hillman adducts: synthesis of β-aryl substituted Baylis-Hillman adducts
Kim, Jeong Mi,Kim, Ko Hoon,Kim, Taek Hyeon,Kim, Jae Nyoung
, p. 3248 - 3251 (2008/09/21)
The first successful intermolecular Heck reaction between Baylis-Hillman adducts and aryl iodides was achieved under the conditions comprising Pd(OAc)2/n-Bu4NBr/KOAc in CH3CN.